Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Monitor your individual tolerance, especially during your first month of treatment
3a, 40% of TA was released in the first 6 h and 86% of TA could be released in the first week
P.KerbyJ
The Phase III trials have been testing tirzepatide as monotherapy, as an add-on to other treatments, and against established glucose-lowering drugs in people with T2D, as well as a weight-loss agent in people with diabetes and obesity
To assess the generalizability of our findings, we performed a post hoc analysis in 12 participants who were on the commercial Control-IQ technology during the last 14 days of the titration period
This insight, combined with your prescriber's clinical judgment, creates a personalized injection strategy that maximizes your weight loss while minimizing complications
